SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000879169-24-000159
Filing Date
2024-10-02
Accepted
2024-10-02 13:01:26
Documents
3
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1727888479.html 4  
1 FORM 4 wk-form4_1727888479.xml 4 3554
2 EX-24 clancy-incytesection16po.htm EX-24 3646
3 clancy-incytesection16po001.jpg GRAPHIC 246041
  Complete submission text file 0000879169-24-000159.txt   347925
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Issuer) CIK: 0000879169 (see all company filings)

IRS No.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12400 | Film No.: 241346122